Conference Coverage
The Latest
IAS 2019: What to Expect in HIV Science
Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
Not Surprisingly, PopART Study Showed Community-Based Services Reduce HIV Incidence
"We don't need to spend another $140 million to find out how to retain people in care," activist David Barr writes. "We need to invest in the kinds of services people need so that they can use treatment easily and effectively."
The HIV Pandemic: Time to Recalibrate and Target the Weak Spots
A conversation with International AIDS Society president Linda-Gail Bekker about a new report on what the future response to HIV should be, released at the the 22nd International AIDS Conference.
Swaziland Dramatically Reduces HIV Incidence Through Test-and-Treat Programs
Swaziland has dramatically reduced the number of new HIV infections while simultaneously getting a substantial portion of the HIV-positive population on treatment.
Fast-Track Cities Share 90-90-90 Progress
Health department representatives from Amsterdam, Nairobi, Paris, San Francisco and São Paulo gathered at the 2017 International AIDS Conference on HIV Science in Paris to share their lessons learned and challenges in preventing new HIV infections....
World Health Organization Pediatric Dosing Tool
A pediatric dosing tool developed by the World Health Organization might assist in the design of clinical trials for dosing in children.
Pre-ART Drug Resistance in Rural South Africa but Limited Clinical Impact With Good Adherence
The prevalence of transmitted drug resistance is above the WHO threshold of 5% in this study conducted in rural South Africa.
To Combat HIV, Sub-Saharan Africa Must Strengthen Its Data Management Systems
"Compared to the cost of annual treatment, the investment made in simple in-house systems, mobile data collection platforms and data transmission platforms would be a small cost," argues Ian Sanne.
CROI Shows the Importance of 90-90-90
A number of important updates were announced at the annual Conference on Retroviruses and Opportunistic Infections that have shown the importance of, and ways to achieve, the 90-90-90 targets.
Efavirenz, Tenofovir and Emtricitabine Associated With Fewest Adverse Birth Outcomes in Botswana
Researchers compared birth outcomes with in-utero exposure from conception to the five most common antiretroviral therapy regimens used in Botswana.